25 results

• Tazverik Removed From Market Due to Cancer Concerns

  March 11, 2026

  Irvin Jackson

  Ipsen is removing its lymphoma drug Tazverik from the market due to increased cancer risks just six years after being granted accelerated approval by the FDA.

• Port Catheter Blood Clot Results in Lawsuit Against Device Manufacturer

  February 4, 2026

  Irvin Jackson

  AngioDynamics is facing a growing number of port catheter lawsuits, including a claim filed by an Arizona woman who alleges that her Vortex port was defectively designed, causing a blood clot that required the device to be removed.

• Tattoo Ink Side Effects Linked to Inflammation, Immune-Cell Death: Study

  December 5, 2025

  Martha Garcia

  Swiss researchers warn that tattoo ink can accumulate in the lymph nodes for months or even permanently, potentially disrupting immune system function.

• Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link

  October 8, 2025

  Russell Maas

  Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety.

• Dupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks

  August 26, 2025

  Irvin Jackson

  Recent studies warn that the eczema treatment Dupixent appears to significantly increase the risk of cutaneous T-cell lymphoma (CTCL).

• Study Finds Individuals With Tattoos Face Increased Lymphoma Risks

  May 31, 2024

  Grace Muller

  A new study warns that people with tattoos face an increased risk of lymphoma, potentially due to ink particles traveling to lymph nodes.

• Ukoniq Side Effects Linked to Increased Risk of Death, FDA Warns, Withdraws Drug Approval

  June 3, 2022

  Irvin Jackson

  The FDA has withdrawn approval for the lymphoma drug Ukoniq after determining the risk of death outweighs any potential benefits.

• Ukoniq FDA Warning Issued Over Increased Risk of Death with Cancer Drug

  February 4, 2022

  Irvin Jackson

  The FDA warns that the relatively new cancer drug, Ukoniq, may increase the risk of death in the lymphoma patients it was designed to treat.

• Coppertone Sunscreen Recall Issued Due to Dangerous Benzene Levels

  October 1, 2021

  Russell Maas

  Coppertone is recalling 12 lots of aerosol sunscreen products due to high levels of benzene, which can cause adverse health effects, including cancer and anemia.

• Exposure to Fracking Chemicals May Increase Risk of Childhood Leukemia, Cancer: Study

  November 2, 2016

  Irvin Jackson

  A new study warns that fracking operations may release cancer-causing chemicals into the air and water, potentially increasing the risk of cancer and childhood leukemia in nearby communities.